However, it appears that if people taking the drugs stop, most regain the weight they lost and the health problems that come with weight gain
In 2005, the first drug, exenatide, derived from Gila monster saliva, hit the market
In all 5 studies, SBP was reduced with oral semaglutide compared to placebo and baseline, with a range of -2.6 mmHg to -12.74 mmHg
Enhance glucose-dependent insulin secretion Reduce glucagon release Slow gastric emptying Increase satiety and reduce appetite Clinical applications include: Type 2 diabetes management Weight management in eligible patients Reduction of cardiovascular risk in selected patients Examples include: Semaglutide Liraglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 receptor agonist) While these therapies have shown remarkable benefits, safe and effective use requires: Proper patient selection Monitoring for adverse effects Lifestyle modifications alongside therapy Guidance from healthcare professionals As healthcare continues to evolve, pharmacists play an important role in patient education, medication safety, and promoting evidence-based use of emerging therapies